Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients

New Microbiologica

Volumn 35, Issue 3, 2012, Pages 279-287

  Gerna, Giuseppe ^a   Lilleri, Daniele ^a   Furione, Milena ^a   Castiglioni, Barbara ^b   Meloni, Federica ^b   Rampino, Teresa ^b   Agozzino, Manuela ^a   Arbustini, Eloisa ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

HCMV end organ disease; HCMV systemic infections; HCMV viral load; Solid organ transplant recipients

Indexed keywords

GANCICLOVIR; VIRUS DNA;

ADULT; ARTICLE; BIOPSY; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PATHOGENICITY; PATHOLOGY; REFERENCE VALUE; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ADULT; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GANCICLOVIR; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; REFERENCE VALUES; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

HUMAN HERPESVIRUS 5;

EID: 84864533232     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ARTHURS S. K., EID A. J., PEDERSEN R. A., KREMERS W. K., COSIO F. G., PATEL R., RAZONABLE R. R. (2008). Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin. Infect. Dis. 46, 840-846. (Pubitemid 351417184)
2. EID A. J., ARTHURS S. K., DEZIEL P. J., WILHELM M. P., RAZONABLE R. R. (2008). Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin. Transplant. 22, 162-170. (Pubitemid 351420009)
3. EID A. J., BAKRI S. J., KIJPITTAYARIT S., RAZONABLE R. R. (2008). Clinical features and outcomes of cy-tomegalovirus retinitis after transplantation. Transpl. Infect. Dis. 10, 13-18. (Pubitemid 351171315)
4. EID A. J., ARTHURS S. K., DEZIEL P. J., WILHELM M. P., RAZONABLE R. R. (2010). Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients. Am. J. Transpl. 10, 157-161.
5. FICA A., CERVERA C., PÉREZ N., MARCOS M. A., RAMÍREZ J., LINARES L., SOTO G., NAVASA M., COFAN F., RICART M. J., PÉREZ-VILLA F., PUMAROLA T., MORENO A. (2007). Immunohistochemically proven cy-tomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transpl. Infect. Dis. 9, 203-210. (Pubitemid 47231211)
6. GERNA G., REVELLO M. G., PERCIVALLE E., MORINI F. (1992). Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quan-titation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 30, 1232-1237.
7. GERNA G., BALDANTI F., SARASINI A., FURIONE M., PERCIVALLE E., REVELLO M. G., ZIPETO D., ZELLA D. (1994). Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob. Agents Chemother. 38, 38-44. (Pubitemid 24018154)
8. GERNA G., VITULO P., ROVIDA F., LILLERI D., PELLEGRINI C., OGGIONNI T., CAMPANINI G., BALDANTI F., REVELLO M. G. (2006). Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J. Med. Virol. 78, 408-416. (Pubitemid 43327842)
9. Erratum in: J. Med. Virol. 80, 1869 (2008).
10. GERNA G., BALDANTI F., TORSELLINI M., MINOLI L., VIGANÒ M., OGGIONNI T., RAMPINO T., CASTIGLIONI B., GOGLIO A., COLLEDAN M., MAMMANA C., NOZZA F., LILLERI D.; BERGAMO TRANSPLANT GROUP. (2007). Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients. A randomized study. Antivir. Ther. 12, 63-72. (Pubitemid 46340427)
11. GERNA G., LILLERI D., ROGNONI V., AGOZZINO M., MELONI F., OGGIONNI T., PELLEGRINI C., ARBUSTINI E., D'ARMINI A. M. (2009). Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients. Am. J. Transplant. 9, 1142-1150.
12. GERNA G., LILLERI D., CHIESA A., ZELINI P., FURIONE M., COMOLLI G., PELLEGRINI C., SARCHI E., MIGOTTO C., BONORA M. R., MELONI F., ARBUSTINI E. (2011). Virologic and immunologic monitoring of cy-tomegalovirus to guide preemptive therapy in solid organ transplantation. Am. J. Transplant. 11, 2463-2471.
13. GRIM S. A., PEREIRA E., GUZMAN G., CLARK N. M. (2010). CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantation. Transplantation. 90, 799-801.
14. GROSSI P., MINOLI L., PERCIVALLE E., IRISH W., VIGANÒ M., GERNA G. (1995). Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation. 59, 847-851.
15. HALME L., LEMPINEN M., AROLA J., SARKIO S., HOCKERSTEDT K., LAUTENSCHLAGER I. (2008). High frequency of gastroduodenal cytomegalovirus infection in liver transplant patients. APMIS 116, 99-106. (Pubitemid 351347592)
16. JANG E.-Y., PARK S. Y., LEE E. J., SONG E. H., CHONG Y. P., LEE S. O., CHOI S. H., WOO J. H., KIM Y. S., KIM S. H. (2009). Diagnostic performance of the cy-tomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin. Infect. Dis. 48, e121-124.
17. KOTTON C. N., KUMAR D., CALIENDO A. M., ASBERG A., CHOU S., SNYDMAN D. R., ALLEN U., HUMAR A., ON BEHALF OF THE TRANSPLANTATION SOCIETY INTERNATIONAL CMV CONSENSUS GROUP. (2010). International consensus guidelines on the management of cy-tomegalovirus in solid organ transplantation. Transplantation. 89, 779-795.
18. LEMONOVICH T. L., WATKINS R. R. (2012). Update on cy-tomegalovirus infections of the gastrointestinal system in solid organ transplant recipients. Curr. Infect. Dis. Rep. 14, 33-40.
19. LJUNGMAN P., GRIFFITHS P., PAYA C. (2002). Definitions of cytomegalovirus infection and disease in transplant recipients. Clin. Infect. Dis. 34, 1094-1097. (Pubitemid 34289682)
20. MARCHETTI S., SANTANGELO R., MANZARA S., D'ONGHIA S., FADDA G., CATTANI P. (2011). Comparison of realtime PCR and pp65 antigen assays for monitoring the development of cytomegalovirus disease in recipients of solid organ and bone marrow transplants. New Microbiol. 34, 157-164.
21. PLACHTER B., NORDIN M., WIRGART B. Z., MACH M., STEIN H., GRILLNER L., JAHN G. (1992). The DNA-binding protein P52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection. Virus Res. 24, 265-276.
22. SHLOBIN O. A., WEST E. E., LECHTZIN N., MILLER S. M., BORJA M., ORENS J. B., DROPULIC L. K., MCDYER J. F. (2006). Persistence cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients. J. Immunol. 176, 2625-2634. (Pubitemid 43201715)
23. WATZINGER F., SUDA M., PREUNER S., BAUMGARTINGER R., EBNER K., BASKOVA L., NIESTERS H. G., LAWITSCHKA A., LION T. (2004). Real-time quantitative PCR assay for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J. Clin. Microbiol. 42, 5189-5198. (Pubitemid 39506229)
24. WIRGART B. Z. (1991). Development of rapid methods for early diagnosis of cytomegalovirus infections (dissertation). Stockholm: Karolinska Hospital.